Tapewire

Nasdaq · USD

TLSI

TriSalus Life Sciences, Inc.

Export transactions ↓
Tapewire entity
5872
SEC CIK
0001826667
Parsed reports
163

Last 12 months

Inside the activity.

12 purchase rows · 18 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202660
Mar 2026014
Apr 202600
May 202661
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202603

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
February 18, 2025 Filed Feb 19, 2025 22:41 UTC
Szela Mary TDirector · CEO AND PRESIDENT
GrantCommon Stock 21,089 $0.00 $0.00
Disclosure

SEC source: 0001415889-25-004682 · form4-02192025_100243.xml · nonDerivative · entry 1

Szela Mary T · CIK 0001410289 · Director · CEO AND PRESIDENT

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 465,348

F1 · shares: Represents grant of restricted stock units (the "RSU Award") payable solely in common stock of the Issuer. The shares subject to the RSU Award shall vest on February 13, 2026, subject to the Reporting Person's continued service with the Issuer on such vesting date.

Read SEC document
February 18, 2025 Filed Feb 19, 2025 22:45 UTC
Cox Bryan F.CHIEF OF RESEARCH
GrantCommon Stock 11,450 $0.00 $0.00
Disclosure

SEC source: 0001415889-25-004685 · form4-02192025_100205.xml · nonDerivative · entry 1

Cox Bryan F. · CIK 0001981787 · CHIEF OF RESEARCH

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 108,457

F1 · shares: Represents grant of restricted stock units (the "RSU Award") payable solely in common stock of the Issuer. 12.5% of the shares subject to the RSU Award shall vest on the grant date of February 18, 2025; 25% of the shares subject to the RSU Award shall vest on each of May 15, 2025, August 15, 2025, and November 14, 2025; and the remaining shares subject to the RSU Award will vest on February 13, 2026, subject to the Reporting Person's continued service with the Issuer on each respective vesting date.

Read SEC document
February 10, 2025 Filed Feb 11, 2025 22:59 UTC
Wahlstrom MatsDirector · 10% owner
OtherSeries A Convertible Preferred Stock · Derivative 44,750 $0.00 Strike: $5.28 $0.00
Disclosure

SEC source: 0001415889-25-003621 · form4-02112025_100210.xml · derivative · entry 1

Wahlstrom Mats · CIK 0001459154 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · By Leonard Capital LLC

Disclosed balance after: 94,750

Underlying: Common Stock · 44,750 shares

Expires not disclosed

F1 · derivative.exercise_price: The conversion price (the "Conversion Price") reflects the reset effective as of February 10, 2025, which reset occurred in accordance with the terms of the Issuer's Certificate of Designations, Preferences and Rights of Series A Convertible Preferred Stock of the Issuer filed with the Delaware Secretary of State on August 10, 2023.

F2 · kind: Effective February 10, 2025, the Conversion Price of the 50,000 shares of Series A Convertible Preferred Stock (the "Preferred Stock") held by the Reporting Person was reset in accordance with the terms of the Preferred Stock, resulting in an increase in the number of shares of Common Stock issuable upon conversion of the Preferred Stock.

F2 · shares: Effective February 10, 2025, the Conversion Price of the 50,000 shares of Series A Convertible Preferred Stock (the "Preferred Stock") held by the Reporting Person was reset in accordance with the terms of the Preferred Stock, resulting in an increase in the number of shares of Common Stock issuable upon conversion of the Preferred Stock.

F3 · derivative.exercise_date: After giving effect to the Conversion Price reset, the Preferred Stock is convertible, in whole or in part, into 94,750 shares of Common Stock of the Issuer (based on a Conversion Price of $5.277 per share, which is subject to adjustment upon the occurrence of certain events) at any time, at the Reporting Person's election.

F4 · derivative.expiration_date: All then outstanding shares of Preferred Stock are automatically converted into shares of the Issuer's Common Stock on August 10, 2027.

F5 · derivative.underlying_shares: Represents the incremental number of shares of Common Stock that are issuable upon conversion of the Preferred Stock as a result of the Conversion Price reset.

F3 · balance_after: After giving effect to the Conversion Price reset, the Preferred Stock is convertible, in whole or in part, into 94,750 shares of Common Stock of the Issuer (based on a Conversion Price of $5.277 per share, which is subject to adjustment upon the occurrence of certain events) at any time, at the Reporting Person's election.

F6 · ownership.nature: The Reporting Person shares voting and investment discretion with his spouse with respect to the shares held directly by Leonard Capital LLC.

Read SEC document
February 10, 2025 Filed Feb 11, 2025 23:04 UTC OtherSeries A Preferred Stock · Derivative 89,501 $0.00 Strike: $5.28 $0.00
Disclosure

SEC source: 0001415889-25-003623 · form4-02112025_110217.xml · derivative · entry 1

MATLIN DAVID J · CIK 0001251956 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 189,501

Underlying: Common Stock · 89,501 shares

Expires not disclosed

F1 · derivative.exercise_price: The conversion price (the "Conversion Price") reflects the reset effective as of February 10, 2025, which reset occurred in accordance with the terms of the Issuer's Certificate of Designations, Preferences and Rights of Series A Convertible Preferred Stock of the Issuer filed with the Delaware Secretary of State on August 10, 2023.

F2 · kind: Effective February 10, 2025, the Conversion Price of the 100,000 shares of Series A Convertible Preferred Stock (the "Preferred Stock") held by the Reporting Person was reset in accordance with the terms of the Preferred Stock, resulting in an increase in the number of shares of Common Stock issuable upon conversion of the Preferred Stock.

F2 · shares: Effective February 10, 2025, the Conversion Price of the 100,000 shares of Series A Convertible Preferred Stock (the "Preferred Stock") held by the Reporting Person was reset in accordance with the terms of the Preferred Stock, resulting in an increase in the number of shares of Common Stock issuable upon conversion of the Preferred Stock.

F3 · derivative.exercise_date: After giving effect to the Conversion Price reset, the Preferred Stock is convertible, in whole or in part, into 189,501 shares of Common Stock of the Issuer (based on a Conversion Price of $5.277 per share, which is subject to adjustment upon the occurrence of certain events) at any time, at the Reporting Person's election.

F4 · derivative.expiration_date: All then outstanding shares of Preferred Stock are automatically converted into shares of the Issuer's Common Stock on August 10, 2027.

F5 · derivative.underlying_shares: Represents the incremental number of shares of Common Stock that are issuable upon conversion of the Preferred Stock as a result of the Conversion Price reset.

F3 · balance_after: After giving effect to the Conversion Price reset, the Preferred Stock is convertible, in whole or in part, into 189,501 shares of Common Stock of the Issuer (based on a Conversion Price of $5.277 per share, which is subject to adjustment upon the occurrence of certain events) at any time, at the Reporting Person's election.

Read SEC document
February 10, 2025 Filed Feb 11, 2025 22:57 UTC OtherSeries A Convertible Preferred Stock · Derivative 205,853 $0.00 Strike: $5.28 $0.00
Disclosure

SEC source: 0001415889-25-003620 · form4-02112025_100256.xml · derivative · entry 1

Frankenius Equity AB · CIK 0001988262 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 435,853

Underlying: Common Stock · 205,853 shares

Expires not disclosed

F1 · derivative.exercise_price: The conversion price (the "Conversion Price") reflects the reset effective as of February 10, 2025, which reset occurred in accordance with the terms of the Issuer's Certificate of Designations, Preferences and Rights of Series A Convertible Preferred Stock of the Issuer filed with the Delaware Secretary of State on August 10, 2023.

F2 · kind: Effective February 10, 2025, the Conversion Price of the 230,000 shares of Series A Convertible Preferred Stock (the "Preferred Stock") held by the Reporting Person was reset in accordance with the terms of the Preferred Stock, resulting in an increase in the number of shares of Common Stock issuable upon conversion of the Preferred Stock.

F2 · shares: Effective February 10, 2025, the Conversion Price of the 230,000 shares of Series A Convertible Preferred Stock (the "Preferred Stock") held by the Reporting Person was reset in accordance with the terms of the Preferred Stock, resulting in an increase in the number of shares of Common Stock issuable upon conversion of the Preferred Stock.

F3 · derivative.exercise_date: After giving effect to the Conversion Price reset, the Preferred Stock is convertible, in whole or in part, into 435,853 shares of Common Stock of the Issuer (based on a Conversion Price of $5.277 per share, which is subject to adjustment upon the occurrence of certain events) at any time, at the Reporting Person's election.

F4 · derivative.expiration_date: All then outstanding shares of Preferred Stock are automatically converted into shares of the Issuer's Common Stock on August 10, 2027.

F5 · derivative.underlying_shares: Represents the incremental number of shares of Common Stock that are issuable upon conversion of the Preferred Stock as a result of the Conversion Price reset.

F3 · balance_after: After giving effect to the Conversion Price reset, the Preferred Stock is convertible, in whole or in part, into 435,853 shares of Common Stock of the Issuer (based on a Conversion Price of $5.277 per share, which is subject to adjustment upon the occurrence of certain events) at any time, at the Reporting Person's election.

Read SEC document
February 05, 2025 Filed Feb 6, 2025 18:09 UTC
Young James EmmettChief Financial Officer
PurchaseCommon Stock 6,000 $5.65 $33,900.00
Disclosure

SEC source: 0001415889-25-003293 · form4-02062025_110257.xml · nonDerivative · entry 1

Young James Emmett · CIK 0002050748 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · By Kathleen A. Young Living Trust

Disclosed balance after: 30,000

F1 · ownership.nature: The Reporting Person is the sole trustee of Kathleen A. Young Living Trust.

Read SEC document
January 30, 2025 Filed Jan 31, 2025 22:54 UTC
Szela Mary TDirector · CEO AND PRESIDENT
PurchaseCommon Stock 5,010 $5.28 $26,452.80
Disclosure

SEC source: 0001415889-25-002536 · form4-01312025_100135.xml · nonDerivative · entry 2

Szela Mary T · CIK 0001410289 · Director · CEO AND PRESIDENT

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 444,259

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.15 to $5.33, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
January 29, 2025 Filed Jan 31, 2025 23:00 UTC GrantDirector Stock Option (right to buy) · Derivative 6,250 $0.00 Strike: $4.89 $0.00
Disclosure

SEC source: 0001415889-25-002541 · form4-01312025_110103.xml · derivative · entry 2

Valle William · CIK 0002018493 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,250

Underlying: Common Stock · 6,250 shares

Expires 2035-01-28

F2 · derivative.exercise_date: The shares subject to the option shall fully vest on the one-year anniversary of the grant date of January 29, 2025, provided that the shares subject to the option will in any case be fully vested on the date of the Issuer's next annual stockholder meeting, subject to the Reporting Person's continued service with the Issuer.

Read SEC document
January 29, 2025 Filed Jan 31, 2025 23:00 UTC GrantDirector Stock Option (right to buy) · Derivative 35,000 $0.00 Strike: $4.89 $0.00
Disclosure

SEC source: 0001415889-25-002541 · form4-01312025_110103.xml · derivative · entry 1

Valle William · CIK 0002018493 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 35,000

Underlying: Common Stock · 35,000 shares

Expires 2035-01-28

F1 · derivative.exercise_date: The shares subject to this stock option vest in three equal annual installments from the vesting commencement date of January 29, 2025, subject to the Reporting Person's continued service with the Issuer on each respective vesting date.

Read SEC document
January 29, 2025 Filed Jan 31, 2025 23:05 UTC GrantDirector Stock Option (right to buy) · Derivative 6,250 $0.00 Strike: $4.89 $0.00
Disclosure

SEC source: 0001415889-25-002546 · form4-01312025_110111.xml · derivative · entry 2

Gordon Gary B. · CIK 0001811354 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,250

Underlying: Common Stock · 6,250 shares

Expires 2035-01-28

F2 · derivative.exercise_date: The shares subject to the option shall fully vest on the one-year anniversary of the grant date of January 29, 2025, provided that the shares subject to the option will in any case be fully vested on the date of the Issuer's next annual stockholder meeting, subject to the Reporting Person's continued service with the Issuer.

Read SEC document
January 29, 2025 Filed Jan 31, 2025 23:05 UTC GrantDirector Stock Option (right to buy) · Derivative 35,000 $0.00 Strike: $4.89 $0.00
Disclosure

SEC source: 0001415889-25-002546 · form4-01312025_110111.xml · derivative · entry 1

Gordon Gary B. · CIK 0001811354 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 35,000

Underlying: Common Stock · 35,000 shares

Expires 2035-01-28

F1 · derivative.exercise_date: The shares subject to this stock option vest in three equal annual installments from the vesting commencement date of January 29, 2025, subject to the Reporting Person's continued service with the Issuer on each respective vesting date.

Read SEC document
January 29, 2025 Filed Jan 31, 2025 22:54 UTC
Szela Mary TDirector · CEO AND PRESIDENT
PurchaseCommon Stock 5,030 $5.03 $25,300.90
Disclosure

SEC source: 0001415889-25-002536 · form4-01312025_100135.xml · nonDerivative · entry 1

Szela Mary T · CIK 0001410289 · Director · CEO AND PRESIDENT

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 439,249

Read SEC document
January 28, 2025 Filed Jan 29, 2025 18:13 UTC
Murphy SeanDirector · Chief Manuf, Strategy&Bus Dev.
PurchaseCommon Stock 15,000 $5.17 $77,550.00
Disclosure

SEC source: 0001415889-25-002291 · form4-01292025_110106.xml · nonDerivative · entry 3

Murphy Sean · CIK 0001685042 · Director · Chief Manuf, Strategy&Bus Dev.

10b5-1 filing: No plan indicated

Ownership: Indirect · By Sean E Murphy TTEE U/A 2/4/2004

Disclosed balance after: 197,732

F3 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.94 to $5.35, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
January 28, 2025 Filed Jan 29, 2025 23:15 UTC
Szela Mary TDirector · CEO AND PRESIDENT
PurchaseCommon Stock 4,716 $5.12 $24,145.92
Disclosure

SEC source: 0001415889-25-002292 · form4-01292025_110101.xml · nonDerivative · entry 3

Szela Mary T · CIK 0001410289 · Director · CEO AND PRESIDENT

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 434,219

F3 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.03 to $5.24, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
January 27, 2025 Filed Jan 29, 2025 18:03 UTC
Young James EmmettChief Financial Officer
GrantEmployee Stock Option (right to buy) · Derivative 75,000 $0.00 Strike: $5.30 $0.00
Disclosure

SEC source: 0001415889-25-002287 · form4-01292025_110141.xml · derivative · entry 3

Young James Emmett · CIK 0002050748 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 75,000

Underlying: Common Stock · 75,000 shares

Expires 2035-01-26

F4 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the option shall vest on the one-year anniversary of the vesting commencement date of January 1, 2025 (the "VCD"), and 1/36th of the remaining shares shall vest each month thereafter on the same day of the month as the VCD (or if there is no corresponding day, on the last day of the month), subject to the Reporting Person's continuous service with the Issuer on each respective vesting date.

Read SEC document
January 27, 2025 Filed Jan 29, 2025 18:03 UTC
Young James EmmettChief Financial Officer
PurchaseCommon Stock 24,000 $5.40 $129,600.00
Disclosure

SEC source: 0001415889-25-002287 · form4-01292025_110141.xml · nonDerivative · entry 2

Young James Emmett · CIK 0002050748 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · By Kathleen A. Young Living Trust

Disclosed balance after: 24,000

F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.11 to $5.54, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

F3 · ownership.nature: The Reporting Person is the sole trustee of Kathleen A. Young Living Trust.

Read SEC document
January 27, 2025 Filed Jan 29, 2025 18:03 UTC
Young James EmmettChief Financial Officer
GrantCommon Stock 12,500 $0.00 $0.00
Disclosure

SEC source: 0001415889-25-002287 · form4-01292025_110141.xml · nonDerivative · entry 1

Young James Emmett · CIK 0002050748 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,726

F1 · shares: Represents grant of restricted stock units (the "RSU Award") payable solely in common stock of the Issuer. The shares subject to the RSU Award vest in four equal annual installments commencing on January 1, 2025, subject to the Reporting Person's continued service with the Issuer on each respective vesting date.

Read SEC document
January 27, 2025 Filed Jan 29, 2025 18:00 UTC
Devlin JodiChief of COMMERC. OPERATIONS
GrantEmployee Stock Option (right to buy) · Derivative 63,750 $0.00 Strike: $5.30 $0.00
Disclosure

SEC source: 0001415889-25-002285 · form4-01292025_110128.xml · derivative · entry 2

Devlin Jodi · CIK 0001992151 · Chief of COMMERC. OPERATIONS

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 63,750

Underlying: Common Stock · 63,750 shares

Expires 2035-01-26

F2 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the option shall vest on the one-year anniversary of the vesting commencement date of January 1, 2025 (the "VCD"), and 1/36th of the remaining shares shall vest each month thereafter on the same day of the month as the VCD (or if there is no corresponding day, on the last day of the month), subject to the Reporting Person's continuous service with the Issuer on each respective vesting date.

Read SEC document
January 27, 2025 Filed Jan 29, 2025 18:00 UTC
Devlin JodiChief of COMMERC. OPERATIONS
GrantCommon Stock 10,625 $0.00 $0.00
Disclosure

SEC source: 0001415889-25-002285 · form4-01292025_110128.xml · nonDerivative · entry 1

Devlin Jodi · CIK 0001992151 · Chief of COMMERC. OPERATIONS

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,125

F1 · shares: Represents grant of restricted stock units (the "RSU Award") payable solely in common stock of the Issuer. The shares subject to the RSU Award vest in four equal annual installments commencing on January 1, 2025, subject to the Reporting Person's continued service with the Issuer on each respective vesting date.

Read SEC document
January 27, 2025 Filed Jan 29, 2025 17:55 UTC
Stevens JenniferCHIEF REGULATORY OFFICER
GrantEmployee Stock Option (right to buy) · Derivative 63,750 $0.00 Strike: $5.30 $0.00
Disclosure

SEC source: 0001415889-25-002283 · form4-01292025_100124.xml · derivative · entry 2

Stevens Jennifer · CIK 0001982621 · CHIEF REGULATORY OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 63,750

Underlying: Common Stock · 63,750 shares

Expires 2035-01-26

F2 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the option shall vest on the one-year anniversary of the vesting commencement date of January 1, 2025 (the "VCD"), and 1/36th of the remaining shares shall vest each month thereafter on the same day of the month as the VCD (or if there is no corresponding day, on the last day of the month), subject to the Reporting Person's continuous service with the Issuer on each respective vesting date.

Read SEC document
January 27, 2025 Filed Jan 29, 2025 17:55 UTC
Stevens JenniferCHIEF REGULATORY OFFICER
GrantCommon Stock 10,625 $0.00 $0.00
Disclosure

SEC source: 0001415889-25-002283 · form4-01292025_100124.xml · nonDerivative · entry 1

Stevens Jennifer · CIK 0001982621 · CHIEF REGULATORY OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 43,408

F1 · shares: Represents grant of restricted stock units (the "RSU Award") payable solely in common stock of the Issuer. The shares subject to the RSU Award vest in four equal annual installments commencing on January 1, 2025, subject to the Reporting Person's continued service with the Issuer on each respective vesting date.

Read SEC document
January 27, 2025 Filed Jan 29, 2025 22:58 UTC
Marshak RichardChief Commercial Officer
GrantEmployee Stock Option (right to buy) · Derivative 75,000 $0.00 Strike: $5.30 $0.00
Disclosure

SEC source: 0001415889-25-002284 · form4-01292025_100134.xml · derivative · entry 2

Marshak Richard · CIK 0001982638 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 75,000

Underlying: Common Stock · 75,000 shares

Expires 2035-01-26

F2 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the option shall vest on the one-year anniversary of the vesting commencement date of January 1, 2025 (the "VCD"), and 1/36th of the remaining shares shall vest each month thereafter on the same day of the month as the VCD (or if there is no corresponding day, on the last day of the month), subject to the Reporting Person's continuous service with the Issuer on each respective vesting date.

Read SEC document
January 27, 2025 Filed Jan 29, 2025 22:58 UTC
Marshak RichardChief Commercial Officer
GrantCommon Stock 12,500 $0.00 $0.00
Disclosure

SEC source: 0001415889-25-002284 · form4-01292025_100134.xml · nonDerivative · entry 1

Marshak Richard · CIK 0001982638 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 46,626

F1 · shares: Represents grant of restricted stock units (the "RSU Award") payable solely in common stock of the Issuer. The shares subject to the RSU Award vest in four equal annual installments commencing on January 1, 2025, subject to the Reporting Person's continued service with the Issuer on each respective vesting date.

Read SEC document
January 27, 2025 Filed Jan 29, 2025 18:13 UTC
Murphy SeanDirector · Chief Manuf, Strategy&Bus Dev.
GrantEmployee Stock Option (right to buy) · Derivative 75,000 $0.00 Strike: $5.30 $0.00
Disclosure

SEC source: 0001415889-25-002291 · form4-01292025_110106.xml · derivative · entry 5

Murphy Sean · CIK 0001685042 · Director · Chief Manuf, Strategy&Bus Dev.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 75,000

Underlying: Common Stock · 75,000 shares

Expires 2035-01-26

F5 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the option shall vest on the one-year anniversary of the vesting commencement date of January 1, 2025 (the "VCD"), and 1/36th of the remaining shares shall vest each month thereafter on the same day of the month as the VCD (or if there is no corresponding day, on the last day of the month), subject to the Reporting Person's continuous service through each such vesting date.

Read SEC document
January 27, 2025 Filed Jan 29, 2025 18:13 UTC
Murphy SeanDirector · Chief Manuf, Strategy&Bus Dev.
PurchaseCommon Stock 15,000 $5.31 $79,650.00
Disclosure

SEC source: 0001415889-25-002291 · form4-01292025_110106.xml · nonDerivative · entry 2

Murphy Sean · CIK 0001685042 · Director · Chief Manuf, Strategy&Bus Dev.

10b5-1 filing: No plan indicated

Ownership: Indirect · By Sean E Murphy TTEE U/A 2/4/2004

Disclosed balance after: 182,732

F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.09 to $5.55, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
January 27, 2025 Filed Jan 29, 2025 18:13 UTC
Murphy SeanDirector · Chief Manuf, Strategy&Bus Dev.
GrantCommon Stock 12,500 $0.00 $0.00
Disclosure

SEC source: 0001415889-25-002291 · form4-01292025_110106.xml · nonDerivative · entry 1

Murphy Sean · CIK 0001685042 · Director · Chief Manuf, Strategy&Bus Dev.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 63,288

F1 · shares: Represents grant of restricted stock units (the "RSU Award") payable solely in common stock of the Issuer. The shares subject to the RSU Award vest in four equal annual installments commencing on January 1, 2025, subject to the Reporting Person's continued service with the Issuer on each respective vesting date.

Read SEC document
January 27, 2025 Filed Jan 29, 2025 23:15 UTC
Szela Mary TDirector · CEO AND PRESIDENT
GrantEmployee Stock Option (right to buy) · Derivative 240,000 $0.00 Strike: $5.30 $0.00
Disclosure

SEC source: 0001415889-25-002292 · form4-01292025_110101.xml · derivative · entry 4

Szela Mary T · CIK 0001410289 · Director · CEO AND PRESIDENT

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 240,000

Underlying: Common Stock · 240,000 shares

Expires 2035-01-26

F4 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the option shall vest on the one-year anniversary of the vesting commencement date of January 1, 2025 (the "VCD"), and 1/36th of the remaining shares shall vest each month thereafter on the same day of the month as the VCD (or if there is no corresponding day, on the last day of the month), subject to the Reporting Person's continuous service with the Issuer on each respective vesting date.

Read SEC document
January 27, 2025 Filed Jan 29, 2025 23:15 UTC
Szela Mary TDirector · CEO AND PRESIDENT
PurchaseCommon Stock 4,826 $5.42 $26,156.92
Disclosure

SEC source: 0001415889-25-002292 · form4-01292025_110101.xml · nonDerivative · entry 2

Szela Mary T · CIK 0001410289 · Director · CEO AND PRESIDENT

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 429,503

F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.25 to $5.45, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
January 27, 2025 Filed Jan 29, 2025 23:15 UTC
Szela Mary TDirector · CEO AND PRESIDENT
GrantCommon Stock 40,000 $0.00 $0.00
Disclosure

SEC source: 0001415889-25-002292 · form4-01292025_110101.xml · nonDerivative · entry 1

Szela Mary T · CIK 0001410289 · Director · CEO AND PRESIDENT

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 424,677

F1 · shares: Represents grant of restricted stock units (the "RSU Award") payable solely in common stock of the Issuer. The shares subject to the RSU Award vest in four equal annual installments commencing on January 1, 2025, subject to the Reporting Person's continued service with the Issuer on each respective vesting date.

Read SEC document
January 27, 2025 Filed Jan 29, 2025 23:09 UTC
Cox Bryan F.CHIEF OF RESEARCH
GrantEmployee Stock Option (right to buy) · Derivative 63,750 $0.00 Strike: $5.30 $0.00
Disclosure

SEC source: 0001415889-25-002289 · form4-01292025_110116.xml · derivative · entry 2

Cox Bryan F. · CIK 0001981787 · CHIEF OF RESEARCH

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 63,750

Underlying: Common Stock · 63,750 shares

Expires 2035-01-26

F2 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the option shall vest on the one-year anniversary of the vesting commencement date of January 1, 2025 (the "VCD"), and 1/36th of the remaining shares shall vest each month thereafter on the same day of the month as the VCD (or if there is no corresponding day, on the last day of the month), subject to the Reporting Person's continuous service with the Issuer on each respective vesting date.

Read SEC document
January 27, 2025 Filed Jan 29, 2025 23:09 UTC
Cox Bryan F.CHIEF OF RESEARCH
GrantCommon Stock 10,625 $0.00 $0.00
Disclosure

SEC source: 0001415889-25-002289 · form4-01292025_110116.xml · nonDerivative · entry 1

Cox Bryan F. · CIK 0001981787 · CHIEF OF RESEARCH

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 97,007

F1 · shares: Represents grant of restricted stock units (the "RSU Award") payable solely in common stock of the Issuer. The shares subject to the RSU Award vest in four equal annual installments commencing on January 1, 2025, subject to the Reporting Person's continued service with the Issuer on each respective vesting date.

Read SEC document
January 02, 2025 Filed Jan 6, 2025 17:54 UTC GrantCommon Stock 10,040 $0.00 $0.00
Disclosure

SEC source: 0001415889-25-000828 · form4-01062025_100110.xml · nonDerivative · entry 1

Hyveled Liselotte · CIK 0002015594 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,040

F1 · shares: Represents grant of Restricted Stock Units (the "RSU Award") payable solely in common stock of the Issuer. The Reporting Person elected to receive the RSU Award in lieu of the 2025 cash Annual Board Service Retainer provided for under the Issuer's Non-Employee Director Compensation Policy. The shares subject to the RSU Award shall vest in equal quarterly installments on each of March 31, June 30, September 30 and December 31, 2025, subject to the Reporting Person's continued service with the Issuer.

Read SEC document
January 02, 2025 Filed Jan 6, 2025 22:57 UTC GrantCommon Stock 10,040 $0.00 $0.00
Disclosure

SEC source: 0001415889-25-000830 · form4-01062025_100110.xml · nonDerivative · entry 1

MATLIN DAVID J · CIK 0001251956 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 941,944

F1 · shares: Represents grant of Restricted Stock Units (the "RSU Award") payable solely in common stock of the Issuer. The Reporting Person elected to receive the RSU Award in lieu of the 2025 cash Annual Board Service Retainer provided for under the Issuer's Non-Employee Director Compensation Policy. The shares subject to the RSU Award shall vest in equal quarterly installments on each of March 31, June 30, September 30 and December 31, 2025, subject to the Reporting Person's continued service with the Issuer.

Read SEC document
December 31, 2024 Filed Jul 1, 2026 20:01 UTC
Marshak RichardChief Commercial Officer
GrantCommon Stock 999 $4.26 $4,255.74
Disclosure

SEC source: 0001628280-26-046501 · wk-form5_1782936102.xml · nonDerivative · entry 2

Marshak Richard · CIK 0001982638 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 35,404

F1 · shares: Represents shares acquired by the Reporting Person through the Issuer's Employee Stock Purchase Plan in a transaction exempt under Rule 16b-3.

Read SEC document
December 31, 2024 Filed Jul 1, 2026 20:03 UTC
Szela Mary TDirector · CEO and President
GrantCommon Stock 3,530 $4.26 $15,037.80
Disclosure

SEC source: 0001628280-26-046511 · wk-form5_1782936210.xml · nonDerivative · entry 1

Szela Mary T · CIK 0001410289 · Director · CEO and President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 513,207

F1 · shares: Represents shares acquired by the Reporting Person through the Issuer's Employee Stock Purchase Plan in a transaction exempt under Rule 16b-3.

Read SEC document
December 17, 2024 Filed Dec 19, 2024 23:07 UTC
Wahlstrom MatsDirector · 10% owner
GrantCommon Stock 25,188 $3.97 $99,996.36
Disclosure

SEC source: 0001415889-24-029907 · form4-12192024_111222.xml · nonDerivative · entry 1

Wahlstrom Mats · CIK 0001459154 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,915

F1 · shares: The shares were issued in connection with the closing of the transaction contemplated by the Securities Purchase Agreement, entered into December 12, 2024, by and between the Issuer and Reporting Person.

Read SEC document
December 17, 2024 Filed Dec 19, 2024 23:03 UTC PurchaseCommon Stock 62,972 $3.97 $249,998.84
Disclosure

SEC source: 0001415889-24-029904 · form4-12192024_111252.xml · nonDerivative · entry 1

Frankenius Equity AB · CIK 0001988262 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,230,748

F1 · shares: The shares were issued in connection with the closing of the transaction contemplated by the Securities Purchase Agreement, entered into December 12, 2024, by and between the Issuer and Reporting Person.

Read SEC document
December 10, 2024 Filed Dec 12, 2024 22:40 UTC SaleCommon Stock 30,000 $3.69 $110,700.00
Disclosure

SEC source: 0001415889-24-029160 · form4-12122024_101213.xml · nonDerivative · entry 1

Desai Arjun JJ · CIK 0001982985 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 247,127

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.55 to $3.90, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
November 22, 2024 Filed Nov 25, 2024 22:53 UTC
Wahlstrom MatsDirector · 10% owner
PurchaseCommon Stock 5,000 $4.55 $22,750.00
Disclosure

SEC source: 0001415889-24-027656 · form4-11252024_101159.xml · nonDerivative · entry 1

Wahlstrom Mats · CIK 0001459154 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,727

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.45 to $4.63, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.

Read SEC document
November 21, 2024 Filed Nov 23, 2024 00:11 UTC
Wahlstrom MatsDirector · 10% owner
PurchaseCommon Stock 8,687 $4.44 $38,570.28
Disclosure

SEC source: 0001415889-24-027587 · form4-11232024_121118.xml · nonDerivative · entry 2

Wahlstrom Mats · CIK 0001459154 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,727

F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.19 to $4.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.

Read SEC document
November 20, 2024 Filed Nov 23, 2024 00:11 UTC
Wahlstrom MatsDirector · 10% owner
PurchaseCommon Stock 2,040 $4.16 $8,486.40
Disclosure

SEC source: 0001415889-24-027587 · form4-11232024_121118.xml · nonDerivative · entry 1

Wahlstrom Mats · CIK 0001459154 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,040

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.99 to $4.29, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.

Read SEC document
November 14, 2024 Filed Nov 16, 2024 00:00 UTC
Marshak RichardSR.VP, CORP. DEV. & STRATEGY
GrantEmployee Stock Option (right to buy) · Derivative 41,250 $0.00 Strike: $4.01 $0.00
Disclosure

SEC source: 0001415889-24-026999 · form4-11162024_121145.xml · derivative · entry 2

Marshak Richard · CIK 0001982638 · SR.VP, CORP. DEV. & STRATEGY

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 41,250

Underlying: Common Stock · 41,250 shares

Expires 2034-11-13

F2 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the option shall vest on the one-year anniversary of the vesting commencement date of November 14, 2024, and 1/36th of the remaining shares shall vest each month thereafter, subject to the Reporting Person's continuous service with the Issuer through each such vesting date.

Read SEC document
November 14, 2024 Filed Nov 16, 2024 00:00 UTC
Marshak RichardSR.VP, CORP. DEV. & STRATEGY
GrantCommon Stock 6,875 $0.00 $0.00
Disclosure

SEC source: 0001415889-24-026999 · form4-11162024_121145.xml · nonDerivative · entry 1

Marshak Richard · CIK 0001982638 · SR.VP, CORP. DEV. & STRATEGY

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 34,126

F1 · shares: Represents grant of restricted stock units (the "RSU Award") payable solely in common stock of the Issuer. The shares subject to the RSU Award vest in four equal annual installments commencing on November 14, 2024, subject to the Reporting Person's continuous service with the Issuer on each such date.

Read SEC document
October 05, 2024 Filed Dec 19, 2024 23:09 UTC
Cox Bryan F.CHIEF SCIENTIFIC & MANUFACT.
SaleCommon Stock 314 $4.44 $1,394.16
Disclosure

SEC source: 0001415889-24-029909 · form4-12192024_111238.xml · nonDerivative · entry 1

Cox Bryan F. · CIK 0001981787 · CHIEF SCIENTIFIC & MANUFACT.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 86,382

F1 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units granted on May 19, 2023 for 4,127 shares.

Read SEC document
September 13, 2024 Filed Sep 13, 2024 21:43 UTC
Szela Mary TDirector · CEO AND PRESIDENT
PurchaseCommon Stock 6,000 $5.00 $30,000.00
Disclosure

SEC source: 0001415889-24-023390 · form4-09132024_090910.xml · nonDerivative · entry 3

Szela Mary T · CIK 0001410289 · Director · CEO AND PRESIDENT

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 384,677

Read SEC document
September 13, 2024 Filed Sep 13, 2024 21:43 UTC
Szela Mary TDirector · CEO AND PRESIDENT
PurchaseCommon Stock 1,295 $4.83 $6,254.85
Disclosure

SEC source: 0001415889-24-023390 · form4-09132024_090910.xml · nonDerivative · entry 2

Szela Mary T · CIK 0001410289 · Director · CEO AND PRESIDENT

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 378,677

Read SEC document
September 12, 2024 Filed Sep 13, 2024 21:43 UTC
Szela Mary TDirector · CEO AND PRESIDENT
PurchaseCommon Stock 7,520 $5.20 $39,104.00
Disclosure

SEC source: 0001415889-24-023390 · form4-09132024_090910.xml · nonDerivative · entry 1

Szela Mary T · CIK 0001410289 · Director · CEO AND PRESIDENT

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 377,382

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.05 to $5.32, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.

Read SEC document
September 10, 2024 Filed Sep 12, 2024 23:06 UTC
Szela Mary TDirector · CEO AND PRESIDENT
PurchaseCommon Stock 5,000 $4.97 $24,850.00
Disclosure

SEC source: 0001415889-24-023320 · form4-09122024_110917.xml · nonDerivative · entry 1

Szela Mary T · CIK 0001410289 · Director · CEO AND PRESIDENT

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 369,862

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.91 to $4.99, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.

Read SEC document
August 28, 2024 Filed Sep 10, 2024 21:42 UTC SaleCommon Stock 9 $5.50 $49.50
Disclosure

SEC source: 0001415889-24-023167 · form4-09102024_090904.xml · nonDerivative · entry 1

Martin George Kelly · CIK 0001982607 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By Varka LLC

Disclosed balance after: 247,176

F1 · balance_after: The shares are held by Varka LLC. The Reporting Person may be deemed to have beneficial ownership of the shares held directly by Varka LLC.

Read SEC document
August 13, 2024 Filed Aug 22, 2024 00:45 UTC GrantDirector stock option (right to buy) · Derivative 15,000 $0.00 Strike: $5.75 $0.00
Disclosure

SEC source: 0001415889-24-021954 · form4-08222024_120852.xml · derivative · entry 1

HICKS KERRY R · CIK 0001110473 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,000

Underlying: Common Stock · 15,000 shares

Expires 2034-08-12

F1 · derivative.exercise_date: The shares subject to the option shall fully vest on the one-year anniversary of the grant date of August 13, 2024, provided that the shares subject to the option will in any case be fully vested on the date of the Issuer's next annual stockholder meeting, subject to the Reporting Person's continued service with the Issuer.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.